TSE:4568
TSE:4568Pharmaceuticals

Daiichi Sankyo (TSE:4568): Revisiting Valuation After ENHERTU’s Landmark First-Line FDA Approval

Daiichi Sankyo Company (TSE:4568) just picked up a major US win, with the FDA approving ENHERTU plus pertuzumab as first line therapy for unresectable or metastatic HER2 positive breast cancer, reshaping expectations around its oncology growth story. See our latest analysis for Daiichi Sankyo Company. The ENHERTU milestone lands after a mixed run in the market, with the latest share price at ¥3,462 and a year to date share price return of about negative 19 percent, even as the five year total...
TSE:7267
TSE:7267Auto

Honda Motor (TSE:7267) Valuation Check After a 33% Share Price Gain Over the Past Year

Honda Motor (TSE:7267) has quietly put up a solid showing for shareholders, with the stock gaining about 33% over the past year even as the past 3 months have cooled slightly. See our latest analysis for Honda Motor. That move has been driven more by a reset in expectations than a sudden surge, with a modestly positive 1 month share price return but a strong 1 year total shareholder return showing longer term momentum is still intact. If Honda’s steady climb has you thinking about what else...